CGT
AVNS

Capital Guardian Trust’s Avanos Medical AVNS Stock Holding History

Capital Guardian Trust’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-48
Closed -$2K – 224
2017
Q1 		$2K Hold
48
– – ﹤0.01% 611
2016
Q4 		$2K Sell
48
-18
-27% -$643 ﹤0.01% 655
2016
Q3 		$2K Sell
66
-20
-23% -$701 ﹤0.01% 667
2016
Q2 		$3K Hold
86
– – ﹤0.01% 632
2016
Q1 		$2K Sell
86
-275
-76% -$7.33K ﹤0.01% 746
2015
Q4 		$12K Hold
361
– – ﹤0.01% 562
2015
Q3 		$10K Sell
361
-199
-36% -$6.94K ﹤0.01% 578
2015
Q2 		$23K Buy
560
+118
+27% +$5.3K ﹤0.01% 487
2015
Q1 		$22K Buy
442
+19
+4% +$880 ﹤0.01% 506
2014
Q4 		$19K Buy
+423
New +$16.6K ﹤0.01% 447

Other funds holding AVNS

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Capital Guardian Trust's AVNS Position: Q2 2017 in Review

Capital Guardian Trust sold out of Avanos Medical (AVNS) in Q2 2017, closing a stake of 48 shares — an estimated $2K sold.

Capital Guardian Trust first reported a position in AVNS in Q4 2014 and held it in 10 quarters. The position peaked at $23K in Q2 2015. 328 funds tracked by Wall St. Rank hold AVNS as of Q2 2017.

  • Capital Guardian Trust reported no remaining Avanos Medical position as of Q2 2017 after selling out during the quarter.
  • Capital Guardian Trust sold 48 Avanos Medical shares in Q2 2017, an estimated $2K.
  • Capital Guardian Trust first reported a position in Avanos Medical in Q4 2014 and held it in 10 quarters.
  • Capital Guardian Trust's Avanos Medical position peaked at $23K in Q2 2015.
  • 328 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2017.

Based on Capital Guardian Trust's 13F filing for Q2 2017, filed 14 Aug 2017.